Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation.
Vaccines (Basel)
; 10(12)2022 Dec 02.
Article
de En
| MEDLINE
| ID: mdl-36560479
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Observational_studies
/
Risk_factors_studies
Langue:
En
Journal:
Vaccines (Basel)
Année:
2022
Type de document:
Article
Pays d'affiliation:
Bangladesh